Antibody · 류마티스관절염

36개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved36 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyCurated CoreFDAstaleRocheApproved

rituximab (Rituxan)

US label: non-Hodgkin lymphoma, CLL, rheumatoid arthritis, GPA/MPA and pemphigus vulgaris; population-specific indicati… · CD20

#CD20#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 1337Status Approved
AntibodyCurated CoreFDAstaleAbbVieApproved

adalimumab (Humira, Hyrimoz, Amjevita)

Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis, axial SpA · TNF-α

#TNF-#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 574Status Approved
AntibodyCurated CorestaleNovartis PharmaceuticalsApproved

Abatacept (Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#BioJungboMoa-pick#Popular+3
Trials 117Status Active
AntibodyLimited DatastaleJanssenPhase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#Popular#monoclonal-antibody+2
Trials 90Status Active
AntibodyCurated CorestaleMario Negri Institute for Pharm…Approved

Certolizumab pegol (Certolizumab pegol)

Rheumatoid Arthritis · Crohn's Disease

#CrohnsDisease#Antibody#Approved#BioJungboMoa-pick#Popular+3
Trials 60Status Active
AntibodyCurated CorestaleGenentech, Inc.Phase 2

Ocrelizumab (Ocrelizumab)

Rheumatoid Arthritis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase2#BioJungboMoa-pick#Popular+4
Trials 58Status Discontinued
AntibodyLimited DatastaleGilead SciencesPhase 1

Andecaliximab (Andecaliximab)

Gastric Adenocarcinoma · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase1#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 3Status Discontinued
AntibodyLimited DatastaleUCB PharmaApproved

CZP (Certolizumab Pegol, Certolizumab Pegol (CZP))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#UCB
Trials 3Status Active
AntibodyLimited DatastaleRochePhase 2

rituximab (MabThera®, MabThera® (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 3Status Discontinued
AntibodyLimited DatastaleNovartis PharmaceuticalsPhase 2

Secukinmab (Secukinmab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Novartis
Trials 3Status Active
AntibodyLimited DatastaleRochePhase 2

rituximab (Rituxan, Rituxan (rituximab))

Rheumatoid Arthritis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase2#monoclonal-antibody#RheumatoidArthritis+1
Trials 2Status Active
AntibodyLimited DatastaleBristol-Myers SquibbPhase 3

Abatacept (ABA, Abatacept, Abatacept (ABA) + Methotrexate (MTX), double-blind (DB))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Bristol-Myers
Trials 1Status Active
AntibodyLimited DatastaleHanyang UniversityPreclinical

Adalimuab, Etanercept, Tocilizumab, or Abatacept (Adalimuab, Etanercept, Tocilizumab, or Abatacept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#Hanyang
Trials 1Status Active
AntibodyLimited DatastaleMerck KGaA, Darmstadt, GermanyPhase 2

Atacicept (Atacicept)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Merck
Trials 1Status Active
AntibodyLimited DatastaleUniversity of CagliariPreclinical

Belimumab in SLE patients / Rituximab in RA patients (Belimumab in SLE patients / Rituximab in RA patients)

Systemic Lupus Erythematosus; Rheumatoid Arthritis · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#monoclonal-antibody#RheumatoidArthritis+1
Trials 1Status Active
AntibodyLimited DatastaleShanghai Biomabs Pharmaceutical…Phase 3

CMAB008 (CMAB008)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleUniversity of Illinois at Chica…Approved

CDP870, tradename Cimzia (Certolizumab pegol, Certolizumab pegol (CDP870, tradename Cimzia))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

adalimumab (Humira, Double-blind adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

GP2013 - A Proposed biosimilar rituximab (GP2013 - A Proposed biosimilar rituximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleBiogenPhase 2

rituximab (IDEC-C2B8, IDEC-C2B8 (rituximab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#monoclonal-antibody#Biogen
Trials 1Status Discontinued

1 / 2 pages

← PreviousNext →